,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,1,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line,Confirmatory,,
1,3,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H226 Non-Small Cell Lung cell line,Confirmatory,,
2,5,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H322M Non-Small Cell Lung cell line,Confirmatory,,
3,7,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H460 Non-Small Cell Lung cell line,Confirmatory,,
4,9,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the HOP-62 Non-Small Cell Lung cell line,Confirmatory,,
5,11,1,1,,112141,249332,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HOP-18 Non-Small Cell Lung cell line,Confirmatory,,
6,13,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line,Confirmatory,,
7,15,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H522 Non-Small Cell Lung cell line,Confirmatory,,
8,17,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the LXFL 529 Non-Small Cell Lung cell line,Confirmatory,,
9,19,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the A549/ATCC Non-Small Cell Lung cell line,Confirmatory,,
10,21,1,1,,112141,249332,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the EKVX Non-Small Cell Lung cell line,Confirmatory,,
11,23,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the LOX IMVI Melanoma cell line,Confirmatory,,
12,25,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the M14 Melanoma cell line,Confirmatory,,
13,27,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the M19-MEL Melanoma cell line,Confirmatory,,
14,29,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line,Confirmatory,,
15,31,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the UACC-62 Melanoma cell line,Confirmatory,,
16,33,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the UACC-257 Melanoma cell line,Confirmatory,,
17,35,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-2 Melanoma cell line,Confirmatory,,
18,37,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line,Confirmatory,,
19,39,1,1,,112141,249332,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-28 Melanoma cell line,Confirmatory,,
20,41,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the PC-3 Prostate cell line,Confirmatory,,
21,43,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line,Confirmatory,,
22,45,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-268 Central Nervous System cell line,Confirmatory,,
23,47,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-295 Central Nervous System cell line,Confirmatory,,
24,49,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line,Confirmatory,,
25,51,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the XF 498 Central Nervous System cell line,Confirmatory,,
26,53,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SNB-19 Central Nervous System cell line,Confirmatory,,
27,55,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SNB-75 Central Nervous System cell line,Confirmatory,,
28,57,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SNB-78 Central Nervous System cell line,Confirmatory,,
29,59,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the U251 Central Nervous System cell line,Confirmatory,,
30,61,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the DMS 273 Small Cell Lung cell line,Confirmatory,,
31,63,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the DMS 114 Small Cell Lung cell line,Confirmatory,,
32,65,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the HT29 Colon cell line,Confirmatory,,
33,67,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the COLO 205 Colon cell line,Confirmatory,,
34,69,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the DLD-1 Colon cell line,Confirmatory,,
35,71,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCT-15 Colon cell line,Confirmatory,,
36,73,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the KM12 Colon cell line,Confirmatory,,
37,75,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the KM20L2 Colon cell line,Confirmatory,,
38,77,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCC-2998 Colon cell line,Confirmatory,,
39,79,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCT-116 Colon cell line,Confirmatory,,
40,81,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SW-620 Colon cell line,Confirmatory,,
41,83,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the MCF7 Breast cell line,Confirmatory,,
42,85,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the MDA-MB-435 Breast cell line,Confirmatory,,
43,87,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line,Confirmatory,,
44,89,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the BT-549 Breast cell line,Confirmatory,,
45,91,1,1,,112141,249332,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the T-47D Breast cell line,Confirmatory,,
46,93,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI/ADR-RES Breast cell line,Confirmatory,,
47,95,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the MDA-MB-231/ATCC Breast cell line,Confirmatory,,
48,97,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the HS 578T Breast cell line,Confirmatory,,
49,99,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-3 Ovarian cell line,Confirmatory,,
50,101,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the IGROV1 Ovarian cell line,Confirmatory,,
51,103,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-OV-3 Ovarian cell line,Confirmatory,,
52,105,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-4 Ovarian cell line,Confirmatory,,
53,107,1,1,,112141,249332,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-5 Ovarian cell line,Confirmatory,,
54,109,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-8 Ovarian cell line,Confirmatory,,
55,111,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the P388 Leukemia cell line,Confirmatory,,
56,113,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the RPMI-8226 Leukemia cell line,Confirmatory,,
57,115,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SR Leukemia cell line,Confirmatory,,
58,117,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the P388/ADR Leukemia cell line,Confirmatory,,
59,119,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the CCRF-CEM Leukemia cell line,Confirmatory,,
60,121,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the K-562 Leukemia cell line,Confirmatory,,
61,123,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the MOLT-4 Leukemia cell line,Confirmatory,,
62,125,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line,Confirmatory,,
63,127,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SN12K1 Renal cell line,Confirmatory,,
64,129,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the A498 Renal cell line,Confirmatory,,
65,131,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the CAKI-1 Renal cell line,Confirmatory,,
66,133,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the RXF 393 Renal cell line,Confirmatory,,
67,135,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the RXF-631 Renal cell line,Confirmatory,,
68,137,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the 786-0 Renal cell line,Confirmatory,,
69,139,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line,Confirmatory,,
70,141,1,1,,112141,249332,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the TK-10 Renal cell line,Confirmatory,,
71,143,1,1,,112141,249332,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line,Confirmatory,,
72,145,1,1,,112141,249332,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line,Confirmatory,,
73,147,1,1,,112141,249332,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the rad52 strain,Other,,
74,149,1,1,,112141,249332,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the wt1 strain,Other,,
75,151,1,1,,112141,249332,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the rad50EPP+ strain,Other,,
76,153,1,1,,112141,249332,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mgt1 strain,Other,,
77,155,1,1,,112141,249332,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the rad50 strain,Other,,
78,157,1,1,,112141,249332,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain,Other,,
79,159,1,1,,112141,249332,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the rad14 strain,Other,,
80,161,1,1,,112141,249332,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain,Other,,
81,163,1,1,,112141,249332,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the CLN2oe strain,Other,,
82,165,1,1,,112141,249332,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain,Other,,
83,167,1,1,,112141,249332,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the bub3 strain,Other,,
84,169,1,1,,112141,249332,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the wt2 strain,Other,,
85,171,1,1,,112141,249332,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mlh1 strain,Other,,
86,173,1,1,,112141,249332,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the sgs1 strain,Other,,
87,175,1,1,,112141,249332,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain,Other,,
88,177,1,1,,112141,249332,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the rad18 strain,Other,,
89,179,1,1,,112141,249332,Inactive,,,,,NCI AIDS Antiviral Assay,Confirmatory,,
90,180,1,1,,112141,249332,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Adenocarcinoma 755 (subcutaneous) in B6D2F1 (BDF1) mice,Other,,
91,182,1,1,,112141,249332,Inconclusive,,,,,"NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia resistant to Adriamycin; NSC 123127, Developed at Scr 06 and 41 (intraperitoneal) in B6D2F1 (BDF1) mice",Other,,
92,184,1,1,,112141,249332,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  ADJ-PC-6 (intraperitoneal) in BALB/cJ mice,Other,,
93,186,1,1,,112141,249332,Unspecified,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Nontumored Animals (Toxicity Test) in B6D2F1 (BDF1) mice,Other,,
94,188,1,1,,112141,249332,Unspecified,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Nontumored Animals (Toxicity Test) in CD2F1 (CDF1) mice,Other,,
95,190,1,1,,112141,249332,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Lymphoma AKR (Transplanted) (intraperitoneal) in AKR/Lw mice,Other,,
96,192,1,1,,112141,249332,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  B16 Melanoma (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
97,194,1,1,,112141,249332,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  B16 Melanoma (subcutaneous) in B6D2F1 (BDF1) mice,Other,,
98,196,1,1,,112141,249332,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  B16 Melanoma (intracerebral) in B6D2F1 (BDF1) mice,Other,,
99,198,1,1,,112141,249332,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  B16 Melanoma (intraperitoneal) in C57BL/6 mice,Other,,
100,200,1,1,,112141,249332,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  B16 Melanoma (intraperitoneal) in B6C3F1 mice,Other,,
101,204,1,1,,112141,249332,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P288 Lymphocytic Leukemia resistant to methotrexate; NSC 740 (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
102,206,1,1,,112141,249332,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  HT29;CX-1 Human Adenocarcinoma (MER+) (intrarenal inoculation) in NU/NU Swiss (nude) mice,Other,,
103,210,1,1,,112141,249332,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Colon 26 Adenocarcinoma (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
104,212,1,1,,112141,249332,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Colon Carcinoma 38 (subcutaneous) in B6D2F1 (BDF1) mice,Other,,
105,216,1,1,,112141,249332,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P288 Lymphocytic Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
106,220,1,1,,112141,249332,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Mammary Adenocarcinoma CD8F1 (subcutaneous) in CD8F1,Other,,
107,222,1,1,,112141,249332,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Ependymoblastoma (intracerebral) in C57BL/6 mice,Other,,
108,224,1,1,,112141,249332,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P335 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
109,232,1,1,,112141,249332,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Lymphosarcoma Gardner 6C3HED (intraperitoneal) in C3AKF1 (CHKRF1) mice,Other,,
110,236,1,1,,112141,249332,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  AK4 Lymphoid Leukemia (intraperitoneal) in C3AKF1 (CHKRF1) mice,Other,,
111,240,1,1,,112141,249332,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Lymphoma 4 (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
112,244,1,1,,112141,249332,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Lymphoma 8 (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
113,246,1,1,,112141,249332,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P1081 Chloroleukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
114,248,1,1,,112141,249332,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
115,250,1,1,,112141,249332,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (subcutaneous) in B6D2F1 (BDF1) mice,Other,,
116,254,1,1,,112141,249332,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intravenous) in B6D2F1 (BDF1) mice,Other,,
117,256,1,1,,112141,249332,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
118,258,1,1,,112141,249332,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (subcutaneous) in CD2F1 (CDF1) mice,Other,,
119,262,1,1,,112141,249332,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Human Lung LX-1 Xenograft (subcutaneous) in NU/NU Swiss (nude) mice,Other,,
120,264,1,1,,112141,249332,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Human Lung LX-1 Xenograft (intrarenal inoculation) in NU/NU Swiss (nude) mice,Other,,
121,266,1,1,,112141,249332,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Human Lung LX-1 Xenograft (intrarenal inoculation) in NU/NU BALB/C (nude) mice,Other,,
122,270,1,1,,112141,249332,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Lewis Lung Carcinoma (subcutaneous) in B6D2F1 (BDF1) mice,Other,,
123,272,1,1,,112141,249332,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Lewis Lung Carcinoma (intramuscular) in B6D2F1 (BDF1) mice,Other,,
124,274,1,1,,112141,249332,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Lewis Lung Carcinoma (intravenous) in B6D2F1 (BDF1) mice,Other,,
125,282,1,1,,112141,249332,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia resistant to A Terephthalanilide; NSC 38280 (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
126,284,1,1,,112141,249332,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia resistant to Methotrexate; NSC 740 (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
127,286,1,1,,112141,249332,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Sarcoma M5076 (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
128,288,1,1,,112141,249332,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Sarcoma M5076 (subcutaneous) in B6D2F1 (BDF1) mice,Other,,
129,290,1,1,,112141,249332,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P1798 Lymphosarcoma (subcutaneous) in unknown mice,Other,,
130,296,1,1,,112141,249332,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Human Mammary Carcinoma MX-1 Xenograft (intrarenal inoculation) in NU/NU Swiss (nude) mice,Other,,
131,308,1,1,,112141,249332,Inactive,,,,,"NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia resistant to 6-MP and 6-Thioguanine; NSC 755, NSC 752 (intraperitoneal) in B6D2F1 (BDF1) mice",Other,,
132,312,1,1,,112141,249332,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  C1498 Myeloid Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
133,314,1,1,,112141,249332,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P1534 Leukemia (intraperitoneal) in DBA/2 mice,Other,,
134,316,1,1,,112141,249332,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P1534 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
135,318,1,1,,112141,249332,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P815 Mast Cell Leukemia (Ascitic) (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
136,320,1,1,,112141,249332,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P329 Reticulum Cell Sarcoma (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
137,322,1,1,,112141,249332,Inactive,,,,,"NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia resistant to Adriamycin; NSC 123127, Developed at Scr 08 (intraperitoneal) in CD2F1 (CDF1) mice",Other,,
138,324,1,1,,112141,249332,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia resistant to AMSA; NSC 249992 (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
139,326,1,1,,112141,249332,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia resistant to Dihydroxy Anthracenedione; NSC 299195 (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
140,328,1,1,,112141,249332,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
141,330,1,1,,112141,249332,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
142,332,1,1,,112141,249332,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  ADJ-PC-20 Plasma Cell (subcutaneous) in unknown mice,Other,,
143,334,1,1,,112141,249332,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intracerebral) in CD2F1 (CDF1) mice,Other,,
144,336,1,1,,112141,249332,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia resistant to Vincristine; NSC 67574 (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
145,338,1,1,,112141,249332,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia resistant to A Terephthalanilide; NSC 38280 (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
146,340,1,1,,112141,249332,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Reticulum Cell Sarcoma (Kelley Mouse) (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
147,342,1,1,,112141,249332,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Sarcoma 180 (subcutaneous) in Swiss mice,Other,,
148,45935,4,2,,164144456,249332,Active,,,0.12589,GI50,Inhibition of proliferation in NCI human CNS tumor cell lines,Confirmatory,12036377.0,
149,45936,4,1,,164144456,249332,Unspecified,,,,,Cytotoxic effect on human CNS tumor cell lines,Other,12036377.0,
150,45937,4,1,,164144456,249332,Unspecified,,,,,Cytostatic effect on human CNS tumor cell lines,Other,12036377.0,
151,52655,4,1,,164144456,249332,Unspecified,,,,,Cytostatic effect on human colon tumor cell lines,Other,12036377.0,
152,99407,4,2,,164144456,249332,Active,,,0.1,GI50,Inhibition of proliferation in NCI human leukemia tumor cell lines,Confirmatory,12036377.0,
153,99410,4,1,,164144456,249332,Unspecified,,,,,Cytotoxic effect on human leukemia tumor cell lines,Other,12036377.0,
154,99411,4,1,,164144456,249332,Unspecified,,,,,Cytostatic effect on human leukemia tumor cell lines,Other,12036377.0,
155,106502,4,2,,164144456,249332,Active,,,0.19952999999999999,GI50,"Inhibition of proliferation in NCI 60 human tumor cell line panel, MG-MID represents mean value",Confirmatory,12036377.0,
156,106503,4,1,,164144456,249332,Unspecified,,,,,"Cytostatic effect on 60 human tumor cell line panel, MG-MID represents mean value",Other,12036377.0,
157,146686,4,2,,164144456,249332,Active,,,0.25119,GI50,Inhibition of proliferation in NCI human non-small cell lung tumor cell lines,Confirmatory,12036377.0,
158,146687,4,1,,164144456,249332,Unspecified,,,,,Cytotoxic effect on human non-small cell lung carcinoma cell lines,Other,12036377.0,
159,146689,4,1,,164144456,249332,Unspecified,,,,,Cytostatic effect on human non-small cell lung carcinoma tumor cell lines,Other,12036377.0,
160,161368,4,1,,164144456,249332,Unspecified,,,,,Cytotoxic effect on human prostate tumor cell lines,Other,12036377.0,
161,219003,4,2,,164144456,249332,Active,,,0.31623,GI50,Inhibition of proliferation in NCI human breast tumor cell lines,Confirmatory,12036377.0,
162,219004,4,1,,164144456,249332,Unspecified,,,,,Cytotoxic effect on human breast tumor cell lines,Other,12036377.0,
163,219005,4,1,,164144456,249332,Unspecified,,,,,Cytostatic effect on human breast tumor cell lines,Other,12036377.0,
164,219716,4,2,,164144456,249332,Active,,,0.1,GI50,Inhibition of proliferation in NCI human colon tumor cell lines,Confirmatory,12036377.0,
165,219717,4,1,,164144456,249332,Unspecified,,,,,Cytotoxic effect on human colon tumor cell lines,Other,12036377.0,
166,222029,4,2,,164144456,249332,Active,,,0.15849000000000002,GI50,Inhibition of proliferation in NCI human melanoma tumor cell lines,Confirmatory,12036377.0,
167,222031,4,1,,164144456,249332,Unspecified,,,,,Cytotoxic effect on human melanoma tumor cell lines,Other,12036377.0,
168,222034,4,1,,164144456,249332,Unspecified,,,,,Cytostatic effect on human melanoma tumor cell lines,Other,12036377.0,
169,223610,4,2,,164144456,249332,Active,,,0.31623,GI50,Inhibition of proliferation in NCI human ovarian tumor cell lines,Confirmatory,12036377.0,
170,223611,4,1,,164144456,249332,Unspecified,,,,,Cytotoxic effect on human ovarian tumor cell lines,Other,12036377.0,
171,223612,4,1,,164144456,249332,Unspecified,,,,,Cytostatic effect on human ovarian tumor cell lines,Other,12036377.0,
172,223654,4,2,,164144456,249332,Active,,,0.12589,GI50,Inhibition of proliferation in NCI human prostate tumor cell lines,Confirmatory,12036377.0,
173,223655,4,1,,164144456,249332,Unspecified,,,,,Cytostatic effect on human prostate tumor cell lines,Other,12036377.0,
174,228382,4,2,,164144456,249332,Active,,,0.31623,GI50,Inhibition of proliferation in NCI human renal tumor cell lines,Confirmatory,12036377.0,
175,228383,4,1,,164144456,249332,Unspecified,,,,,Cytotoxic effect on human renal tumor cell lines,Other,12036377.0,
176,228384,4,1,,164144456,249332,Unspecified,,,,,Cytostatic effect on human renal tumor cell lines,Other,12036377.0,
177,228572,4,1,,164144456,249332,Unspecified,,,,,"Cytotoxic effect on 60 human tumor cell line panel, MG-MID represents mean value",Other,12036377.0,
178,245783,4,1,,164144456,249332,Unspecified,,,,,Total growth inhibition of human CNS cell line at 10E-3 M concentration,Other,16107161.0,
179,245785,4,1,,164144456,249332,Unspecified,,,,,Total growth inhibition of human Colon cell line at 10E-3 M concentration,Other,16107161.0,
180,245787,4,1,,164144456,249332,Unspecified,,,,,Total growth inhibition of human NSCLC cell line at 10E-3 M concentration,Other,16107161.0,
181,245789,4,1,,164144456,249332,Unspecified,,,,,Total growth inhibition of human Renal cell line at 10E-3 M concentration,Other,16107161.0,
182,245791,4,1,,164144456,249332,Unspecified,,,,,Total growth inhibition of human MG-MID cell line at 10E-3 M concentration,Other,16107161.0,
183,245793,4,1,,164144456,249332,Unspecified,,,,,Total growth inhibition of human Breast cell line at 10E-3 M concentration,Other,16107161.0,
184,245796,4,1,,164144456,249332,Unspecified,,,,,Total growth inhibition of human Leukemia cell line at 10E-3 M concentration,Other,16107161.0,
185,245798,4,1,,164144456,249332,Unspecified,,,,,Total growth inhibition of human Melanoma cell line at 10E-3 M concentration,Other,16107161.0,
186,245800,4,1,,164144456,249332,Unspecified,,,,,Total growth inhibition of human Ovarian cell line at 10E-3 M concentration,Other,16107161.0,
187,245802,4,1,,164144456,249332,Unspecified,,,,,Total growth inhibition of human Prostate cell line at 10E-3 M concentration,Other,16107161.0,
188,247431,4,1,,164144456,249332,Unspecified,,,,,Growth inhibitory concentration dissolved in DMSO against human CNS cell line at 10E-3 M concentration,Other,16107161.0,
189,247433,4,1,,164144456,249332,Unspecified,,,,,Growth inhibitory concentration dissolved in DMSO against human Colon cell line at 10E-3 M concentration,Other,16107161.0,
190,247436,4,1,,164144456,249332,Unspecified,,,,,Growth inhibitory concentration dissolved in DMSO against human NSCLC cell line at 10E-3 M concentration,Other,16107161.0,
191,247438,4,1,,164144456,249332,Unspecified,,,,,Growth inhibitory concentration dissolved in DMSO against human Renal cell line at 10E-3 M concentration,Other,16107161.0,
192,247440,4,1,,164144456,249332,Unspecified,,,,,Growth inhibitory concentration dissolved in DMSO against human Breast cell line at 10E-3 M concentration,Other,16107161.0,
193,247442,4,1,,164144456,249332,Unspecified,,,,,Growth inhibitory concentration dissolved in DMSO against human MG-MID cell line at 10E-3 M concentration,Other,16107161.0,
194,247444,4,1,,164144456,249332,Unspecified,,,,,Growth inhibitory concentration dissolved in DMSO against human Ovarian cell line at 10E-3 M concentration,Other,16107161.0,
195,247446,4,1,,164144456,249332,Unspecified,,,,,Growth inhibitory concentration dissolved in DMSO against human Melanoma cell line at 10E-3 M concentration,Other,16107161.0,
196,247448,4,1,,164144456,249332,Unspecified,,,,,Growth inhibitory concentration dissolved in DMSO against human Prostate cell line at 10E-3 M concentration,Other,16107161.0,
197,247450,4,1,,164144456,249332,Unspecified,,,,,Growth inhibitory concentration dissolved in DMSO against human leukemia cell line at 10E-3 M concentration,Other,16107161.0,
198,247603,6,2,,164144456,249332,Active,,,0.0001,IC50,Cytotoxic activity against human tumor Aro cell line,Confirmatory,15857148.0,
199,247612,6,2,,164144456,249332,Active,,,0.1,IC50,Cytotoxic activity against human tumor PT45 cell line,Confirmatory,15857148.0,
200,247630,6,2,,164144456,249332,Unspecified,,,100.0,IC50,Cytotoxic activity against human tumor A-172 cell line,Confirmatory,15857148.0,
201,247631,6,2,,164144456,249332,Active,,,0.1,IC50,Cytotoxic activity against human tumor C8305 cell line,Confirmatory,15857148.0,
202,247632,6,2,,164144456,249332,Active,,,0.1,IC50,Cytotoxic activity against human tumor HT-29 cell line,Confirmatory,15857148.0,
203,247633,6,2,,164144456,249332,Active,,,0.01,IC50,Cytotoxic activity against human tumor MCF-7 cell line,Confirmatory,15857148.0,
204,247634,6,2,,164144456,249332,Active,,,0.001,IC50,Cytotoxic activity against human tumor SW 13 cell line,Confirmatory,15857148.0,
205,247645,6,2,,164144456,249332,Active,,,0.1,IC50,Cytotoxic activity against human tumor Hep 3B cell line,Confirmatory,15857148.0,
206,247646,6,2,,164144456,249332,Active,,,0.1,IC50,Cytotoxic activity against human tumor Hep G2 cell line,Confirmatory,15857148.0,
207,247660,6,2,,164144456,249332,Active,,,0.01,IC50,Cytotoxic activity against human tumor Igrov-1 cell line,Confirmatory,15857148.0,
208,247661,6,2,,164144456,249332,Active,,,0.01,IC50,Cytotoxic activity against human tumor Ovcar-3 cell line,Confirmatory,15857148.0,
209,247672,6,2,,164144456,249332,Active,,,0.1,IC50,Cytotoxic activity against human tumor NCI-H295 cell line,Confirmatory,15857148.0,
210,247691,6,2,,164144456,249332,Active,,,0.1,IC50,Cytotoxic activity against human tumor PLC/PRF/5 cell line,Confirmatory,15857148.0,
211,247715,6,2,,164144456,249332,Active,,,0.01,IC50,Cytotoxic activity against human tumor Mia Paca 2 cell line,Confirmatory,15857148.0,
212,249122,4,1,,164144456,249332,Unspecified,,,,,Cytotoxic effect dissolved in DMSO against CNS cell line at 10E-3 M concentration,Other,16107161.0,
213,249129,4,1,,164144456,249332,Unspecified,,,,,Cytotoxic effect dissolved in DMSO against Colon cell line at 10E-3 M concentration,Other,16107161.0,
214,249131,4,1,,164144456,249332,Unspecified,,,,,Cytotoxic effect dissolved in DMSO against NSCLC cell line at 10E-3 M concentration,Other,16107161.0,
215,249133,4,1,,164144456,249332,Unspecified,,,,,Cytotoxic effect dissolved in DMSO against Renal cell line at 10E-3 M concentration,Other,16107161.0,
216,249135,4,1,,164144456,249332,Unspecified,,,,,Cytotoxic effect dissolved in DMSO against Breast cell line at 10E-3 M concentration,Other,16107161.0,
217,249137,4,1,,164144456,249332,Unspecified,,,,,Cytotoxic effect dissolved in DMSO against MG-MID cell line at 10E-3 M concentration,Other,16107161.0,
218,249139,4,1,,164144456,249332,Unspecified,,,,,Cytotoxic effect dissolved in DMSO against Ovarian cell line at 10E-3 M concentration,Other,16107161.0,
219,249141,4,1,,164144456,249332,Unspecified,,,,,Cytotoxic effect dissolved in DMSO against Leukemia cell line at 10E-3 M concentration,Other,16107161.0,
220,249143,4,1,,164144456,249332,Unspecified,,,,,Cytotoxic effect dissolved in DMSO against Melanoma cell line at 10E-3 M concentration,Other,16107161.0,
221,249145,4,1,,164144456,249332,Unspecified,,,,,Cytotoxic effect dissolved in DMSO against Prostate cell line at 10E-3 M concentration,Other,16107161.0,
222,272805,6,2,,164144456,249332,Active,,,0.1,GI50,Anticancer activity against leukemia cancer cell lines of NCI60 panel,Confirmatory,17154522.0,
223,272806,7,1,,164144456,249332,Unspecified,,,,GI50,Anticancer activity against NSCLC cancer cell lines of NCI60 panel,Confirmatory,17154522.0,
224,272807,7,1,,164144456,249332,Unspecified,,,,GI50,Anticancer activity against colon cancer cell lines of NCI60 panel,Confirmatory,17154522.0,
225,272808,7,1,,164144456,249332,Unspecified,,,,GI50,Anticancer activity against CNS cancer cell lines of NCI60 panel,Confirmatory,17154522.0,
226,272809,7,1,,164144456,249332,Unspecified,,,,GI50,Anticancer activity against melanoma cancer cell lines of NCI60 panel,Confirmatory,17154522.0,
227,272810,7,1,,164144456,249332,Unspecified,,,,GI50,Anticancer activity against ovarian cancer cell lines of NCI60 panel,Confirmatory,17154522.0,
228,272811,7,1,,164144456,249332,Unspecified,,,,GI50,Anticancer activity against renal cancer cell lines of NCI60 panel,Confirmatory,17154522.0,
229,272812,7,1,,164144456,249332,Unspecified,,,,GI50,Anticancer activity against prostate cancer cell lines of NCI60 panel,Confirmatory,17154522.0,
230,272813,7,1,,164144456,249332,Unspecified,,,,GI50,Anticancer activity against breast cancer cell lines of NCI60 panel,Confirmatory,17154522.0,
231,286653,6,3,,164144456,249332,Unspecified,,,,,Cytotoxicity against human SMMC7721 cells after 48 hrs,Other,17432904.0,
232,286654,6,2,,164144456,249332,Unspecified,,,,,Cytotoxicity against human HL60 cells after 48 hrs,Other,17432904.0,
233,286655,6,3,,164144456,249332,Unspecified,,,,,Cytotoxicity against human L02 cells after 48 hrs,Other,17432904.0,
234,291345,6,3,,164144456,249332,Active,,,0.1,GI50,Antitumor activity against leukemia cells,Confirmatory,17559205.0,
235,291346,7,1,,164144456,249332,Unspecified,,,,GI50,Antitumor activity against NSCLC cells,Confirmatory,17559205.0,
236,291347,7,1,,164144456,249332,Unspecified,,,,GI50,Antitumor activity against colon tumor cells,Confirmatory,17559205.0,
237,291348,7,1,,164144456,249332,Unspecified,,,,GI50,Antitumor activity against CNS tumor cells,Confirmatory,17559205.0,
238,291349,7,1,,164144456,249332,Unspecified,,,,GI50,Antitumor activity against melanoma cells,Confirmatory,17559205.0,
239,291350,7,1,,164144456,249332,Unspecified,,,,GI50,Antitumor activity against renal tumor cells,Confirmatory,17559205.0,
240,291351,7,1,,164144456,249332,Unspecified,,,,GI50,Antitumor activity against prostate tumor cells,Confirmatory,17559205.0,
241,291352,7,1,,164144456,249332,Unspecified,,,,GI50,Antitumor activity against ovarian tumor cells,Confirmatory,17559205.0,
242,291353,7,1,,164144456,249332,Unspecified,,,,GI50,Antitumor activity against breast tumor cells,Confirmatory,17559205.0,
243,340790,5,3,,164144456,249332,Active,,,0.25119,GI50,Cytotoxicity against human Non-small cell lung carcinoma cells,Confirmatory,18598018.0,
244,340791,5,3,,164144456,249332,Active,,,0.1,GI50,Cytotoxicity against human colon cancer cells,Confirmatory,18598018.0,
245,340792,5,3,,164144456,249332,Active,,,0.12589,GI50,Cytotoxicity against human central nervous system cancer cells,Confirmatory,18598018.0,
246,340793,5,3,,164144456,249332,Active,,,0.15849000000000002,GI50,Cytotoxicity against human melanoma cells,Confirmatory,18598018.0,
247,340794,5,3,,164144456,249332,Active,,,0.31623,GI50,Cytotoxicity against human ovarian cancer cells,Confirmatory,18598018.0,
248,340795,5,3,,164144456,249332,Active,,,0.31623,GI50,Cytotoxicity against human renal cancer cells,Confirmatory,18598018.0,
249,340796,5,3,,164144456,249332,Active,,,0.12589,GI50,Cytotoxicity against human prostate cancer cells,Confirmatory,18598018.0,
250,340797,5,3,,164144456,249332,Active,,,0.31623,GI50,Cytotoxicity against human breast cancer cells,Confirmatory,18598018.0,
251,340798,5,3,,164144456,249332,Active,,,0.1,GI50,Cytotoxicity against human leukemia cells,Confirmatory,18598018.0,
252,347106,8,1,,164144456,249332,Unspecified,,,,GI50,Antitumor activity against human Leukemia cells after 48 hrs by SRB assay,Confirmatory,19006285.0,
253,347107,8,1,,164144456,249332,Unspecified,,,,GI50,Antitumor activity against human NSCLC cells after 48 hrs by SRB assay,Confirmatory,19006285.0,
254,347108,8,1,,164144456,249332,Unspecified,,,,GI50,Antitumor activity against human Colon cancer cells after 48 hrs by SRB assay,Confirmatory,19006285.0,
255,347109,8,1,,164144456,249332,Unspecified,,,,GI50,Antitumor activity against human CNS cancer cells after 48 hrs by SRB assay,Confirmatory,19006285.0,
256,347110,8,1,,164144456,249332,Unspecified,,,,GI50,Antitumor activity against human Melanoma cells after 48 hrs by SRB assay,Confirmatory,19006285.0,
257,347111,8,1,,164144456,249332,Unspecified,,,,GI50,Antitumor activity against human ovarian cancer cells after 48 hrs by SRB assay,Confirmatory,19006285.0,
258,347112,8,1,,164144456,249332,Unspecified,,,,GI50,Antitumor activity against human renal cancer cells after 48 hrs by SRB assay,Confirmatory,19006285.0,
259,347113,8,1,,164144456,249332,Unspecified,,,,GI50,Antitumor activity against human prostate cancer cells after 48 hrs by SRB assay,Confirmatory,19006285.0,
260,347114,8,1,,164144456,249332,Unspecified,,,,GI50,Antitumor activity against human Breast cancer cells after 48 hrs by SRB assay,Confirmatory,19006285.0,
261,480507,5,2,,164144456,249332,Active,,,0.1,GI50,Growth inhibition of human leukemia cell by NCI-CLS assay,Confirmatory,20395150.0,
262,480508,5,2,,164144456,249332,Active,,,0.2,GI50,Growth inhibition of human NSCLC cell by NCI-CLS assay,Confirmatory,20395150.0,
263,480509,5,2,,164144456,249332,Active,,,0.1,GI50,Growth inhibition of human colon cancer cell by NCI-CLS assay,Confirmatory,20395150.0,
264,480510,5,2,,164144456,249332,Active,,,0.1,GI50,Growth inhibition of human CNS cancer cell by NCI-CLS assay,Confirmatory,20395150.0,
265,480511,5,2,,164144456,249332,Active,,,0.2,GI50,Growth inhibition of human melanoma cell by NCI-CLS assay,Confirmatory,20395150.0,
266,480512,5,2,,164144456,249332,Active,,,0.3,GI50,Growth inhibition of human ovarian cancer cell by NCI-CLS assay,Confirmatory,20395150.0,
267,480513,5,2,,164144456,249332,Active,,,0.3,GI50,Growth inhibition of human renal cancer cell by NCI-CLS assay,Confirmatory,20395150.0,
268,480514,5,2,,164144456,249332,Active,,,0.1,GI50,Growth inhibition of human prostate cancer cell by NCI-CLS assay,Confirmatory,20395150.0,
269,480515,5,2,,164144456,249332,Active,,,0.3,GI50,Growth inhibition of human breast cancer cell by NCI-CLS assay,Confirmatory,20395150.0,
270,499202,4,2,,164144456,249332,Active,,,0.1,GI50,Growth inhibition of human leukemia cells after 48 hrs,Confirmatory,20684599.0,
271,499203,4,2,,164144456,249332,Active,,,0.25,GI50,Growth inhibition of human NSCLC cells after 48 hrs,Confirmatory,20684599.0,
272,499204,4,2,,164144456,249332,Active,,,0.1,GI50,Growth inhibition of human colon cancer cells after 48 hrs,Confirmatory,20684599.0,
273,499205,4,2,,164144456,249332,Active,,,0.13,GI50,Growth inhibition of human CNS cancer cells after 48 hrs,Confirmatory,20684599.0,
274,499206,4,2,,164144456,249332,Active,,,0.16,GI50,Growth inhibition of human melanoma cells after 48 hrs,Confirmatory,20684599.0,
275,499207,4,2,,164144456,249332,Active,,,0.32,GI50,Growth inhibition of human Ovarian cancer cells after 48 hrs,Confirmatory,20684599.0,
276,499208,4,2,,164144456,249332,Active,,,0.32,GI50,Growth inhibition of human renal cancer cells after 48 hrs,Confirmatory,20684599.0,
277,499209,4,2,,164144456,249332,Active,,,0.13,GI50,Growth inhibition of human prostate cancer cells after 48 hrs,Confirmatory,20684599.0,
278,499210,4,2,,164144456,249332,Active,,,0.32,GI50,Growth inhibition of human breast cancer cells after 48 hrs,Confirmatory,20684599.0,
279,516589,4,2,,164144456,249332,Active,,,0.0029,IC50,Cytotoxicity against human LNCAP cells after 72 hrs by alamar blue assay,Confirmatory,20732809.0,
280,516590,4,2,,164144456,249332,Active,,,0.011000000000000001,IC50,Cytotoxicity against human PC3 cells after 72 hrs by alamar blue assay,Confirmatory,20732809.0,
281,521220,3,3,,164144456,249332,Active,,,,,Inhibition of neurosphere proliferation of mouse neural precursor cells by MTT assay,Other,17417631.0,
282,524790,7,2,,164144456,249332,Active,,,0.1,IC50,Antiplasmodial activity against Plasmodium falciparum 3D7 after 72 hrs by SYBR green assay,Confirmatory,19734910.0,
283,524791,7,2,,164144456,249332,Active,,,1.0,IC50,Antiplasmodial activity against Plasmodium falciparum 7G8 after 72 hrs by SYBR green assay,Confirmatory,19734910.0,
284,524792,7,2,,164144456,249332,Active,,,0.19952999999999999,IC50,Antiplasmodial activity against Plasmodium falciparum D10 after 72 hrs by SYBR green assay,Confirmatory,19734910.0,
285,524793,7,2,,164144456,249332,Active,,,0.1,IC50,Antiplasmodial activity against Plasmodium falciparum Dd2 after 72 hrs by SYBR green assay,Confirmatory,19734910.0,
286,524794,7,1,,164144456,249332,Active,,,3.16228,IC50,Antiplasmodial activity against Plasmodium falciparum GB4 after 72 hrs by SYBR green assay,Confirmatory,19734910.0,
287,524795,7,2,,164144456,249332,Active,,,1.58489,IC50,Antiplasmodial activity against Plasmodium falciparum HB3 after 72 hrs by SYBR green assay,Confirmatory,19734910.0,
288,524796,7,1,,164144456,249332,Active,,,0.05012,IC50,Antiplasmodial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green assay,Confirmatory,19734910.0,
289,588209,2,3,,164144456,249332,Unspecified,,,,,Literature-mined public compounds from Greene et al multi-species hepatotoxicity modelling dataset,Other,20553011.0,
290,588210,2,4,,164144456,249332,Unspecified,,,,,Human drug-induced liver injury (DILI) modelling dataset from Ekins et al,Other,20843939.0,
291,675705,2,3,,164144456,249332,Active,,,0.1,GI50,Cytotoxicity against human leukemia cells after 48 hrs,Confirmatory,22283430.0,
292,675706,2,2,,164144456,249332,Active,,,0.25,GI50,Cytotoxicity against human NSCLC cells after 48 hrs,Confirmatory,22283430.0,
293,675707,2,3,,164144456,249332,Active,,,0.1,GI50,Cytotoxicity against human COLON cells after 48 hrs,Confirmatory,22283430.0,
294,675708,2,3,,164144456,249332,Active,,,0.13,GI50,Cytotoxicity against human CNS cancer cells after 48 hrs,Confirmatory,22283430.0,
295,675709,2,3,,164144456,249332,Active,,,0.16,GI50,Cytotoxicity against human melanoma cells after 48 hrs,Confirmatory,22283430.0,
296,675710,2,3,,164144456,249332,Active,,,0.32,GI50,Cytotoxicity against human ovarian cancer cells after 48 hrs,Confirmatory,22283430.0,
297,675711,2,3,,164144456,249332,Active,,,0.32,GI50,Cytotoxicity against human renal cancer cells after 48 hrs,Confirmatory,22283430.0,
298,675712,2,3,,164144456,249332,Active,,,0.13,GI50,Cytotoxicity against human prostate cancer cells after 48 hrs,Confirmatory,22283430.0,
299,675713,2,3,,164144456,249332,Active,,,0.32,GI50,Cytotoxicity against human breast cancer cells after 48 hrs,Confirmatory,22283430.0,
300,697852,1,7,,164144456,249332,Unspecified,14916521.0,,,,Inhibition of electric eel AChE at 2 mg/ml by Ellman's method,Other,23062825.0,
301,697853,1,7,,164144456,249332,Unspecified,21362409.0,100033901.0,,,Inhibition of horse BChE at 2 mg/ml by Ellman's method,Other,23062825.0,
302,718278,1,2,,164144456,249332,Active,,,0.017,IC50,Cytotoxicity against human NFF cells after 72 hrs by alamar blue assay,Confirmatory,23215348.0,
303,718279,1,2,,164144456,249332,Active,,,0.015,IC50,Cytotoxicity against human PC3 cells after 72 hrs by alamar blue assay,Confirmatory,23215348.0,
304,718280,1,3,,164144456,249332,Active,,,0.031,IC50,Cytotoxicity against human HEK cells after 72 hrs by alamar blue assay,Confirmatory,23215348.0,
305,718281,1,2,,164144456,249332,Active,,,0.0061,IC50,Cytotoxicity against human LNCAP cells after 72 hrs by alamar blue assay,Confirmatory,23215348.0,
306,718282,1,2,,164144456,249332,Active,,,0.036000000000000004,IC50,Cytotoxicity against human HeLa cells after 72 hrs by alamar blue assay,Confirmatory,23215348.0,
307,718283,1,2,,164144456,249332,Active,,,0.02,IC50,Cytotoxicity against human A549 cells after 72 hrs by alamar blue assay,Confirmatory,23215348.0,
308,735323,1,2,,164144456,249332,Active,,,0.0169,IC50,Cytotoxicity against human NFF cells assessed as inhibition of cell viability after 72 hrs by alamar blue assay,Confirmatory,23489291.0,
309,735326,1,3,,164144456,249332,Active,,,0.0153,IC50,Cytotoxicity against human PC3 cells assessed as inhibition of cell viability after 72 hrs by alamar blue assay,Confirmatory,23489291.0,
310,735328,1,2,,164144456,249332,Active,,,0.0358,IC50,Cytotoxicity against human HeLa cells assessed as inhibition of cell viability after 72 hrs by alamar blue assay,Confirmatory,23489291.0,
311,1124065,1,1,,164144456,249332,Unspecified,,,,,"Antitumor activity against mouse P1534 cells allografted in DBA2 mouse assessed as tumor growth inhibition at 0.10 mg/kg, ip administered daily for 8 to 10 days",Other,430477.0,
312,1124066,1,1,,164144456,249332,Unspecified,,,,,"Antitumor activity against mouse P1534 cells allografted in DBA2 mouse assessed as tumor growth inhibition at 0.20 mg/kg, ip administered daily for 8 to 10 days",Other,430477.0,
313,1124067,1,1,,164144456,249332,Unspecified,,,,,"Antitumor activity against mouse P1534 cells allografted in DBA2 mouse assessed as tumor growth inhibition at 0.25 mg/kg, ip administered daily for 8 to 10 days",Other,430477.0,
314,1124075,1,1,,164144456,249332,Unspecified,,,,,Toxicity in iv dosed mouse assessed as lethality,Other,430477.0,
315,1124080,1,1,,164144456,249332,Unspecified,,,,,"Antitumor activity against mouse P388/S cells allografted in CD2F1 mouse assessed as increase in host lifespan at 1.67 mg/kg, ip administered on days 1, 5 and 9",Other,430477.0,
316,1124081,1,1,,164144456,249332,Unspecified,,,,,"Antitumor activity against mouse P388/S cells allografted in CD2F1 mouse assessed as increase in host lifespan at 1.00 mg/kg, ip administered on days 1, 5 and 9",Other,430477.0,
317,1124082,1,1,,164144456,249332,Unspecified,,,,,"Antitumor activity against mouse P388/S cells allografted in CD2F1 mouse assessed as increase in host lifespan at 0.60 mg/kg, ip administered on days 1, 5 and 9",Other,430477.0,
318,1124083,1,1,,164144456,249332,Unspecified,,,,,"Antitumor activity against mouse P388/S cells allografted in CD2F1 mouse assessed as increase in host lifespan at 0.36 mg/kg, ip administered on days 1, 5 and 9",Other,430477.0,
319,1124086,1,1,,164144456,249332,Unspecified,,,,,"Antitumor activity against mouse P388/VCR cells allografted in CD2F1 mouse assessed as increase in host lifespan at 1.00 mg/kg, ip administered on days 1, 5 and 9",Other,430477.0,
320,1124087,1,1,,164144456,249332,Unspecified,,,,,"Antitumor activity against mouse P388/VCR cells allografted in CD2F1 mouse assessed as increase in host lifespan at 0.60 mg/kg, ip administered on days 1, 5 and 9",Other,430477.0,
321,1124088,1,1,,164144456,249332,Unspecified,,,,,"Antitumor activity against mouse P388/VCR cells allografted in CD2F1 mouse assessed as increase in host lifespan at 0.36 mg/kg, ip administered on days 1, 5 and 9",Other,430477.0,
322,1124089,1,1,,164144456,249332,Unspecified,,,,,"Antitumor activity against mouse P388/VCR cells allografted in B6D2F1 mouse assessed as increase in host lifespan at 1.20 mg/kg, ip administered on days 1, 5 and 9",Other,430477.0,
323,1124090,1,1,,164144456,249332,Unspecified,,,,,"Antitumor activity against mouse P388/VCR cells allografted in B6D2F1 mouse assessed as increase in host lifespan at 0.90 mg/kg, ip administered on days 1, 5 and 9",Other,430477.0,
324,1124091,1,1,,164144456,249332,Unspecified,,,,,"Antitumor activity against mouse P388/VCR cells allografted in B6D2F1 mouse assessed as increase in host lifespan at 0.60 mg/kg, ip administered on days 1, 5 and 9",Other,430477.0,
325,1124094,1,1,,164144456,249332,Unspecified,,,,,"Toxicity in CD2F1 mouse allografted with mouse P388/VCR cells at 1.67 mg/kg, ip administered on days 1, 5 and 9",Other,430477.0,
326,1124099,1,1,,164144456,249332,Unspecified,,,,,"Antitumor activity against mouse P388/VCR/I/63 cells allografted in Dublin-CDF1 mouse assessed as day of host death at 1.5 mg/kg, ip administered on days 1, 5 and 9 (Rvb = 10 days)",Other,430477.0,
327,1124104,1,1,,164144456,249332,Unspecified,,,,,"Antitumor activity against mouse P388/VCR/I/63 cells allografted in Dublin-CDF1 mouse assessed as increase in host lifespan at 1.5 mg/kg, ip administered on days 1, 5 and 9",Other,430477.0,
328,1124107,1,1,,164144456,249332,Unspecified,,,,,Mitotic arrest in CHO cells assessed as increase in cell accumulation at 0.02 ug/ml,Other,430477.0,
329,1124108,1,1,,164144456,249332,Unspecified,,,,,Mitotic arrest in CHO cells assessed as increase in cell accumulation at 0.002 ug/ml,Other,430477.0,
330,1124109,1,1,,164144456,249332,Unspecified,,,,,Displacement of [3H]VLB from tubulin in pig brain by competitive assay,Other,430477.0,
331,1124112,1,1,,164144456,249332,Unspecified,,,,,Cytotoxicity against CHO cells at 0.02 ug/ml,Other,430477.0,
332,1127355,1,1,,164144456,249332,Unspecified,,,,GI50,Cytotoxicity against human leukemia cells after 48 hrs,Confirmatory,24747749.0,
333,1127356,1,1,,164144456,249332,Unspecified,,,,GI50,Cytotoxicity against human NSCLC cells after 48 hrs,Confirmatory,24747749.0,
334,1127357,1,1,,164144456,249332,Unspecified,,,,GI50,Cytotoxicity against human colon cancer cells after 48 hrs,Confirmatory,24747749.0,
335,1127358,1,1,,164144456,249332,Unspecified,,,,GI50,Cytotoxicity against human melanoma cells after 48 hrs,Confirmatory,24747749.0,
336,1127359,1,1,,164144456,249332,Unspecified,,,,GI50,Cytotoxicity against human ovarian cancer cells after 48 hrs,Confirmatory,24747749.0,
337,1127360,1,1,,164144456,249332,Unspecified,,,,GI50,Cytotoxicity against human renal cancer cells after 48 hrs,Confirmatory,24747749.0,
338,1127361,1,1,,164144456,249332,Unspecified,,,,GI50,Cytotoxicity against human prostate cancer cells after 48 hrs,Confirmatory,24747749.0,
339,1127362,1,1,,164144456,249332,Unspecified,,,,GI50,Cytotoxicity against human breast cancer cells after 48 hrs,Confirmatory,24747749.0,
340,1127363,1,1,,164144456,249332,Unspecified,,,,GI50,Cytotoxicity against human CNS cancer cells after 48 hrs,Confirmatory,24747749.0,
341,1147719,1,1,,164144456,249332,Unspecified,,,,,"Antitumor activity against mouse Ridgeway osteogenic sarcoma cells allografted in mouse at 0.1 to 0.2 mg/kg/day, ip",Other,412968.0,
342,1147723,1,1,,164144456,249332,Unspecified,,,,,"Antitumor activity against mouse Gardner lymphosarcoma cell allografted in mouse at 0.1 to 0.2 mg/kg/day, ip",Other,412968.0,
343,1147727,1,1,,164144456,249332,Unspecified,,,,,Acute toxicity in ip dosed mouse,Other,412968.0,
344,1147731,1,1,,164144456,249332,Inactive,,,,,Antitumor activity against mouse P388 cells allografted in mouse assessed as survival at 1.8 mg/kg/day after 1 day,Other,412968.0,
345,1147732,1,1,,164144456,249332,Unspecified,,,,,"Antitumor activity against mouse P1534(J) cells allografted in mouse assessed as tumor growth inhibition at 0.25 mg/kg/day, ip administered from day 1 to day 9 relative to unreated control",Other,412968.0,
346,1147736,1,1,,164144456,249332,Unspecified,,,,,Toxicity in ip dosed mouse allografted with mouse P1534(J) cells administered from day 1 to day 9,Other,412968.0,
347,1147740,1,1,,164144456,249332,Inactive,,,,,Antitumor activity against mouse P388 cells allografted in mouse assessed as survival at 1.2 mg/kg/day after 1 day,Other,412968.0,
348,1147745,1,1,,164144456,249332,Unspecified,,,,,"Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as mean survival time at 0.60 mg/kg/day, ip administered on day 1, 5 and 9 (Rvb = 20.0 days)",Other,412968.0,
349,1147747,1,1,,164144456,249332,Unspecified,,,,,"Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as mean survival time at 1 mg/kg/day, ip administered on day 1, 5 and 9 (Rvb = 20.0 days)",Other,412968.0,
350,1147748,1,1,,164144456,249332,Unspecified,,,,,"Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as mean survival time at 1.67 mg/kg/day, ip administered on day 1, 5 and 9 (Rvb = 20.0 days)",Other,412968.0,
351,1147749,1,1,,164144456,249332,Unspecified,,,,,"Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in life span at 0.33 mg/kg/day, ip administered from day 1 to day 9 relative to untreated control",Other,412968.0,
352,1147751,1,1,,164144456,249332,Unspecified,,,,,"Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in life span at 0.22 mg/kg/day, ip administered from day 1 to day 9 relative to untreated control",Other,412968.0,
353,1147758,1,1,,164144456,249332,Unspecified,,,,,"Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in life span at 4 mg/kg/day, ip after 1 day",Other,412968.0,
354,1147759,1,1,,164144456,249332,Unspecified,,,,,"Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in life span at 2.7 mg/kg/day, ip after 1 day",Other,412968.0,
355,1147760,1,1,,164144456,249332,Unspecified,,,,,"Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in life span at 1.8 mg/kg/day, ip after 1 day",Other,412968.0,
356,1147761,1,1,,164144456,249332,Unspecified,,,,,"Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in life span at 1.2 mg/kg/day, ip after 1 day",Other,412968.0,
357,1147765,1,1,,164144456,249332,Unspecified,,,,,Toxicity in ip dosed mouse allografted with mouse p388 cells administered from day 1 to day 9,Other,412968.0,
358,1147766,1,1,,164144456,249332,Unspecified,,,,,Toxicity in ip dosed mouse allografted with mouse p388 cells after 1 day,Other,412968.0,
359,1147767,1,1,,164144456,249332,Unspecified,,,,,"Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as mean survival time at 0.36 mg/kg/day, ip administered on day 1, 5 and 9 (Rvb = 20.0 days)",Other,412968.0,
360,1147768,1,1,,164144456,249332,Unspecified,,,,,"Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as mean survival time at 0.216 mg/kg/day, ip administered on day 1, 5 and 9 (Rvb = 20.0 days)",Other,412968.0,
361,1147774,1,1,,164144456,249332,Unspecified,,,,,"Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as increase in life span at 1.67 mg/kg/day, ip administered on day 1, 5 and 9 measured for 56 days relative to untreated control",Other,412968.0,
362,1147775,1,1,,164144456,249332,Unspecified,,,,,"Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as increase in life span at 1 mg/kg/day, ip administered on day 1, 5 and 9 measured for 56 days relative to untreated control",Other,412968.0,
363,1147776,1,1,,164144456,249332,Unspecified,,,,,"Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as increase in life span at 0.60 mg/kg/day, ip administered on day 1, 5 and 9 measured for 56 days relative to untreated control",Other,412968.0,
364,1147777,1,1,,164144456,249332,Unspecified,,,,,"Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as increase in life span at 0.36 mg/kg/day, ip administered on day 1, 5 and 9 measured for 56 days relative to untreated control",Other,412968.0,
365,1147778,1,1,,164144456,249332,Unspecified,,,,,"Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as increase in life span at 0.216 mg/kg/day, ip administered on day 1, 5 and 9 measured for 56 days relative to untreated control",Other,412968.0,
366,1147784,1,1,,164144456,249332,Unspecified,,,,,"Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as mean survival time at 1.67 mg/kg/day, ip administered on day 5, 9 and 13 (Rvb = 20.0 days)",Other,412968.0,
367,1147785,1,1,,164144456,249332,Unspecified,,,,,"Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as mean survival time at 1 mg/kg/day, ip administered on day 5, 9 and 13 (Rvb = 20.0 days)",Other,412968.0,
368,1147786,1,1,,164144456,249332,Unspecified,,,,,"Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as mean survival time at 0.60 mg/kg/day, ip administered on day 5, 9 and 13 (Rvb = 20.0 days)",Other,412968.0,
369,1147787,1,1,,164144456,249332,Unspecified,,,,,"Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as mean survival time at 0.36 mg/kg/day, ip administered on day 5, 9 and 13 (Rvb = 20.0 days)",Other,412968.0,
370,1147788,1,1,,164144456,249332,Unspecified,,,,,"Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as mean survival time at 0.216 mg/kg/day, ip administered on day 5, 9 and 13 (Rvb = 20.0 days)",Other,412968.0,
371,1147794,1,1,,164144456,249332,Unspecified,,,,,"Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as increase in life span at 1.67 mg/kg/day, ip administered on day 5, 9 and 13 measured for 56 days relative to untreated control",Other,412968.0,
372,1147795,1,1,,164144456,249332,Unspecified,,,,,"Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as increase in life span at 1 mg/kg/day, ip administered on day 5, 9 and 13 measured for 56 days relative to untreated control",Other,412968.0,
373,1147796,1,1,,164144456,249332,Unspecified,,,,,"Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as increase in life span at 0.60 mg/kg/day, ip administered on day 5, 9 and 13 measured for 56 days relative to untreated control",Other,412968.0,
374,1147797,1,1,,164144456,249332,Unspecified,,,,,"Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as increase in life span at 0.36 mg/kg/day, ip administered on day 5, 9 and 13 measured for 56 days relative to untreated control",Other,412968.0,
375,1147798,1,1,,164144456,249332,Unspecified,,,,,"Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as increase in life span at 0.216 mg/kg/day, ip administered on day 5, 9 and 13 measured for 56 days relative to untreated control",Other,412968.0,
376,1147825,1,1,,164144456,249332,Unspecified,,,,,Acute toxicity in rat,Other,412968.0,
377,1147826,1,1,,164144456,249332,Unspecified,,,,,Neurotoxicity in iv dosed chicken assessed as neuromuscular disturbance by measuring loss of balance,Other,412968.0,
378,1147827,1,1,,164144456,249332,Unspecified,,,,,Neurotoxicity in iv dosed monkey assessed as leukopenia,Other,412968.0,
379,1147828,1,1,,164144456,249332,Unspecified,,,,,Neurotoxicity in iv dosed monkey assessed as peripheral neuropathy,Other,412968.0,
380,1147835,1,1,,164144456,249332,Inactive,,,,,Antitumor activity against mouse P388 cells allografted in mouse assessed as survival at 0.22 mg/kg/day administered from day 1 to day 9,Other,412968.0,
381,1159620,1,1,,164144456,249332,Active,,,,,Summary of drug indications.,Other,,
